Similar articles

• Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.

  Shin DH, Hong MK. Shin DH, et al. Expert Rev Cardiovasc Ther. 2012 Oct;10(10):1273-85. doi: 10.1586/erc.12.113. Expert Rev Cardiovasc Ther. 2012. PMID: 23190066 Review.
• Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.

  Shen Y, Shen WF. Shen Y, et al. Chin Med J (Engl). 2015 Mar 20;128(6):711-3. doi: 10.4103/0366-6999.152446. Chin Med J (Engl). 2015. PMID: 25758260 Free PMC article. No abstract available.
• Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.

  Helft G. Helft G. Arch Cardiovasc Dis. 2013 May;106(5):271-3. doi: 10.1016/j.acvd.2013.03.060. Epub 2013 May 27. Arch Cardiovasc Dis. 2013. PMID: 23769401 No abstract available.
• Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).

  Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G; PRODIGY Investigators. Valgimigli M, et al. JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11. JACC Cardiovasc Interv. 2014. PMID: 24332420 Clinical Trial.
• Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.

  Lemesle G, Paparoni F, Delhaye C, Bonello L, Lablanche JM. Lemesle G, et al. Hosp Pract (1995). 2011 Oct;39(4):32-40. doi: 10.3810/hp.2011.10.920. Hosp Pract (1995). 2011. PMID: 22056821 Review.